Biomaterial Database

[Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities]. 1990

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

UI	MeSH Term	Description	Entries
D007866	Leg	The inferior part of the lower extremity between the KNEE and the ANKLE.	Legs
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D010919	Placebos	Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.	Sham Treatment
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D004341	Drug Evaluation	Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.	Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004743	Enkephalin, Leucine	One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.	Leucine Enkephalin,5-Leucine Enkephalin,Leu(5)-Enkephalin,Leu-Enkephalin,5 Leucine Enkephalin,Enkephalin, 5-Leucine,Leu Enkephalin
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D001162	Arteriosclerosis Obliterans	Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.	Obliterans, Arteriosclerosis
D013565	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.	Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Rehabilitation treatment of arteriosclerosis obliterans of the lower extremities].

August 1988, Wiadomosci lekarskie (Warsaw, Poland : 1960),

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Arterial reconstructive treatment in arteriosclerosis obliterans of the lower extremities].

January 1983, Revista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie,

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Endovascular treatment of multilevel arteriosclerosis obliterans of lower extremities].

September 2010, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Diagnosis and treatment of arteriosclerosis obliterans of the lower extremities].

January 1991, Khirurgiia,

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Butylsympathol in the treatment of arteriosclerosis obliterans of the lower extremities].

April 1963, La Semana medica,

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Thermotopography of the lower extremities in arteriosclerosis obliterans].

July 1985, Vrachebnoe delo,

V A Dudko, and N A Fedorova, and V A Didenko, and G K Zoloev

[Fibrinolysis in arteriosclerosis obliterans of the lower extremities].

January 1961, Polskie Archiwum Medycyny Wewnetrznej,